Reflections from the J.P. Morgan Healthcare Conference

Highlights from JP Morgan 2026

Accelerating Health Care Innovation in 2026

As our understanding of disease grows, so does the pace of health care innovations, from personalized medicine and smart devices to AI advancements. How the industry manages these changes—plus historical ones like the supply chain—is creating new possibilities.

Accelerating Health Care Innovation in 2026

Accelerating Health Care Innovation in 2026

As our understanding of disease grows, so does the pace of health care innovations, from personalized medicine and smart devices to AI advancements. How the industry manages these changes—plus historical ones like the supply chain—is creating new possibilities.
Digital & AI: Separating Reality from Hype

Digital & AI: Separating Reality from Hype

Digital and AI solutions dominated conversations at the J.P. Morgan Healthcare Conference this year. But how much of it is just wishful thinking? A panel of experts contemplated how far we’ve really come and the new solutions technology provides.
Charting the Way Forward in Health Care

Charting the Way Forward in Health Care

Novartis CEO Vas Narasimhan and BCG Global Chair Rich Lesser shared insights from the J.P. Morgan Healthcare Conference, along with predictions for where health care is headed in 2026 and beyond.
Changing Cancer Care at Scale

Changing Cancer Care at Scale

Xavier Avat of Moffitt Cancer Center explains how scaling AI and digitized workflows can cut weeks from cancer care timelines and improve patient outcomes.
Clinical-Grade AI Drives New Models of Care

Clinical-Grade AI Drives New Models of Care

Munjal Shah of Hippocratic AI explains how AI enables innovative approaches to prevention, follow-up, and patient access.
Reimagining Access with Long-Acting Treatments

Reimagining Access with Long-Acting Treatments

Christophe Douat, CEO of Medincell, explains how long-acting injectables can improve adherence, lower costs, and expand access to care in low- and middle-income countries.
Partnering to Unlock AI’s Next Wave in Health Care

Partnering to Unlock AI’s Next Wave in Health Care

Munjal Shah of Hippocratic AI, and BCG’s Ashkan Afkhami discuss how BCG and Hippocratic's collaboration aims to move generative AI from experimentation to scaled impact across life sciences and health care.
When Neurological Disease Outpaces the Care Model

When Neurological Disease Outpaces the Care Model

As stroke and dementia rates rise worldwide, Moleac CEO David Picard discusses why existing care pathways leave too many patients behind—and where science can still change outcomes.
Value Creation as the Test for AI in Health Care

Value Creation as the Test for AI in Health Care

For AI success, health care companies need to be on board with the value creation that the technology can achieve, says BCG’s Sabrina Kristic.
How Actionable Hormone Data Can Transform Women’s Health

How Actionable Hormone Data Can Transform Women’s Health